✦ LIBER ✦

FDA Perspective on Clinical Trial Design for Cardiovascular Devices

✍ Scribed by Eric Chen; Wolf Sapirstein; Chul Ahn; Julie Swain; Bram Zuckerman

Book ID: 116262385
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 94 KB
Volume: 82
Category: Article
ISSN: 0003-4975
DOI: 10.1016/j.athoracsur.2006.07.044

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FDA perspective on clinical trial design

FDA perspective on clinical trial design for femoropopliteal stent correction of peripheral vascular insufficiency cardiovascular devices

✍ Jennifer Goode; Wolf Sapirstein; Bram Zuckerman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

The article by Rocha-Singh et al. [1]. on behalf of the VIVA Physicians Incorporate (VPI) in this issue of the Catheterization and Cardiac Interventions addresses the challenge to designing clinical trials for devices intended to correct femoropopliteal arterial insufficiency. As discussed in this a

FDA’S Perspectives on Cardiovascular Dev

FDA’S Perspectives on Cardiovascular Devices

✍ Eric A. Chen; Sonna M. Patel-Raman; Kathryn O’Callaghan; Matthew G. Hillebrenner 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 89 KB

The FDA and designing clinical trials fo

The FDA and designing clinical trials for chronic cutaneous ulcers

✍ Maderal, Andrea D.; Vivas, Alejandra C.; Eaglstein, William H.; Kirsner, Robert 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 267 KB

FDA perspective on objective performance

FDA perspective on objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia

✍ Allison Kumar; Steven S. Brooks; Kenneth Cavanaugh; Bram Zuckerman 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Fda Perspective on Study Design for Ther

Fda Perspective on Study Design for Therapies for Severe Sepsis

✍ William Schwieterman; Rosemary Roberts 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 86 KB

A Summary of the FDA-NIMH-MATRICS Worksh

A Summary of the FDA-NIMH-MATRICS Workshop on Clinical Trial Design for Neurocognitive Drugs for Schizophrenia

✍ Buchanan, R. W 📂 Article 📅 2005 🏛 Oxford University Press 🌐 English ⚖ 198 KB